网站主页>>>项目整合>>>其它产品项目整合
项目整合的本质是一项集合成方法学、反应工程学与过程分析技术于一体的系统工程。其核心逻辑可以概括为以下几点:源头优选:利用如N-硝胺化学等底层方法学突破,从分子层面颠覆传统高成本、高污染路线。过程强化:依托连续流技术,攻克有机金属试剂应用、光化学反应放大等“不可能”任务,实现高危工艺的本质安全。系统集成:整合“反应-淬灭-分离”全流程,利用微流控与在线分析技术,消除批次间的差异,实现药品制造的连续化与智能化。当前,中间体工艺研发正在经历从“经验驱动”向“数据驱动”的转变。AI辅助路线设计、自动化高通量筛选与连续制造平台的结合,将使得“分子结构与最优工艺路径”之间的映射关系逐渐清晰。未来的竞争优势,将属于那些能够将底层化学创新与先进工程技术进行无缝整合的研发体系。
备注: 根据相关法律法规, 本站点不显示有法律约束管制的产品, 如有遗漏, 请自行鉴别,或提交我们及时更新撤除.
如有产品相关项目调研推广服务, 请致函联系我们

客户展示

示例图片

其它产品项目整合

  • o-Iodohippurate Sodium CAS Registry Number: 133-17-5 邻碘马尿酸钠


    CAS Name: N-(2-Iodobenzoyl)glycine monosodium salt
    Additional Names: sodium o-iodohippurate
    Trademarks: Hippodin; Jodairol
    Percent Composition: C 33.05%, H 2.16%, I 38.80%, N 4.28%, Na 7....
    Literature References: "Contains not less than 38.5% nor more than 39% iodine, when calcd to the dried substance." Prepd by the condensation of o-iodobenzoic acid with glycine, and treatment with NaOH soln: A. P. Sachs, US 2135474 (1938 to Zonite Prods.). Diagnostic use in post-transplant renography: H. Huland, K. Bischoff, J. Urol. 129, 925 (1983); J.-I. D. Jorgensen, J. Ladefoged, Dan. Med. Bull. 34, 50 (1987).

  • Levoglucosenone CAS Registry Number: 37112-31-5 左旋葡萄糖酮


    CAS Name: (1S,5R)-6,8-Dioxabicyclo[3.2.1]oct-2-en-4-one
    Additional Names: 1,6-anhydro-3,4-dideoxy-b-D-glycero-hex-3-enopyranos-2-ulose; 1,6-anhydro-3,4-dideoxy-D3-b-D-pyranosen-2-one
    Percent...
    Literature References: (-)-Form is a pyrolysis product of cellulose and cellulose-containing materials including pulp and paper waste products. Prepn from cellulosic materials: Y. Halpern et al., J. Org. Chem. 38, 204 (1973); and decompn reactions: F. Shafizadeh, P. P. S. Chin, Carbohydr. Res. 46, 149 (1976). Prepn from Kraft paper: eidem, ibid. 58, 79 (1977). Synthesis of (-)-form: M. Shibagaki et al., Chem. Lett. 1990, 307; of (+) and (-) enantiomers: T. Taniguchi et al., Synlett 1996, 971. MS analysis: Y. Halpern, J. P. Hoppesch, J. Org. Chem. 50, 1556 (1985). Electrochemistry: C. Z. Smith et al., J. Chem. Res. Synop. 1987, 88. Stereoselective reactivity: F. Shafizadeh et al., Carbohydr. Res. 71, 169 (1979). Cycloaddition reactions: idem et al., ibid. 114, 71 (1983); A. J. Blake et al., Tetrahedron 48, 8053 (1992). Michael addition reactions: M. G. Essig, Carbohydr. Res. 156, 225 (1986); A. V. Samet et al., 61, 8786 (1996). Applications in chiral carbohydrate synthesis: Y. Gelas-Mialhe et al., Heterocycles 24, 931 (1986); Z. J. Witczak, Pure Appl. Chem. 66, 2189 (1994); R. Blattner, D. M. Page, J. Carbohydr. Chem. 13, 27 (1994).

  • Nimbiol CAS Registry Number: 561-95-5 12-羟基-13-甲基罗汉松-8,11,13-三烯-7-酮


    CAS Name: (4aS-trans)-2,3,4,4a,10,10a-Hexahydro-6-hydroxy-1,1,4a,7-tetramethyl-9(1H)-phenanthrenone
    Additional Names: 6-hydroxy-7-methyl-9-oxopodocarpane
    Percent Composition: C 79.37%, H 8.8...
    Literature References: (+)-Form found in the bark of the neem tree, Azadirachta indica A. Juss. (Melia azadirachta L.), Meliaceae: P. Sengupta et al., Chem. Ind. (London) 1958, 861. Structure: P. Sengupta et al., Tetrahedron 10, 45 (1960). Also obtained by conversion of podocarpic acid: Bible, ibid. 11, 22 (1960); Wenkert et al., J. Am. Chem. Soc. 83, 2320 (1961). Total synthesis of (±)-form: W. L. Meyer et al., J. Org. Chem. 40, 3686 (1975). Synthesis of (±)-methyl ether: Ramachandran, Dutta, J. Chem. Soc. 1960, 4766; Delobelle, Fétizon, Bull. Soc. Chim. Fr. 1961, 1900; Nasipuri, Roy, J. Indian Chem. Soc. 40, 327 (1963).

  • Hexadimethrine Bromide CAS Registry Number: 28728-55-4 海美溴铵


    CAS Name: N,N,N',N'-Tetramethyl-1,6-hexanediamine polymer with 1,3-dibromopropane
    Additional Names: polymer of N,N,N',N'-tetramethylhexamethylenediamine and trimethylene bromide; poly(N,N,N',N'...
    Literature References: (C13H30Br2N2)x. Toxicity study: Kimura et al., Toxicol. Appl. Pharmacol. 1, 185 (1959).

  • Brazilin CAS Registry Number: 474-07-7 巴西苏木素; 苏枋精


    CAS Name: (6aS-cis)-7,11b-Dihydrobenz[b]indeno[1,2-d]pyran-3,6a,9,10(6H)-tetrol
    Additional Names: brasilin; C.I. Natural Red 24; C.I. 75280
    Percent Composition: C 67.13%, H 4.93%, O 27.94%
    Literature References: (May crystallize as the mono- or hemihydrate). From Caesalpinia echinata Lam. (Brazil-wood), or C. sappan L. (sappan-wood), Leguminosae. Isoln and structure: Perkin et al., J. Chem. Soc. 1928, 1504; Pfeiffer et al., Ber. 63, 1301 (1930). Synthesis of (±)-form: Dann, Hofmann, Ann. 667, 116 (1963); Kirkiacharian, Billet, Bull. Soc. Chim. Fr. 1972, 3292. Synthesis, resolution: Morsingh, Robinson, Tetrahedron 26, 281 (1970). Stereochemistry: Craig et al., J. Org. Chem. 30, 1573 (1965); Colour Index vol. 4 (3rd ed., 1971) p 4628. Review: Robinson, Bull. Soc. Chim. Fr. 1958, 125-134.

  • Levetiracetam CAS Registry Number: 102767-28-2 左乙拉西坦


    CAS Name: (aS)-a-Ethyl-2-oxo-1-pyrrolidineacetamide
    Additional Names: 2(S)-(2-oxopyrrolidin-1-yl)butyramideTrademarks: Keppra (UCB)
    Percent Composition: C 56.45%, H 8.29%, N 16.46%, O 18.80%
    Literature References: (S)-Enantiomer of the ethyl analog of piracetam, q.v. Prepn: J. Gobert et al., EP 162036; eidem, US 4943639 (1985, 1990 both to UCB). HPLC-UV determn in plasma: J. Martens-Lobenhoffer, S. M. Bode-Böger, J. Chromatogr. B 819, 197 (2005). Clinical evaluation in refractory partial seizures: S. D. Shorvon et al., Epilepsia 41, 1179 (2000); E. Ben-Menachem, U. Falter, ibid. 1276. Review of pharmacokinetics: P. N. Patsalos, Pharmacol. Ther. 85, 77-85 (2000); of clinical efficacy: E. Ben-Menachem, Expert Opin. Pharmacother. 4, 2079-2088 (2003); of safety and tolerability: D. E. Briggs, J. A. French, Expert Opin. Drug Saf. 3, 415-424 (2004).

  • Darvan® (Celanese) CAS Registry Number: 9003-24-1


    Additional Names: Vinylidene cyanide-vinyl acetate copolymer
    Trademarks: Darlan; Travis
    Literature References: Methylenemalononitrile copolymer with vinyl acetate contg about equal parts of each component. Polymerization of vinylidene cyanide with vinyl acetate: Gilbert et al., J. Am. Chem. Soc. 78, 1669 (1956); Gilbert, Miller, US 2615866 and Sayre, US 2975158 (1952, 1961, both to B. F. Goodrich). Review: R. W. Moncrieff, Man-Made Fibres (John Wiley, New York, 4th ed., 1963) pp 488-494. Approximate structure:

  • Nivalenol CAS Registry Number: 23282-20-4 瓜萎镰菌醇


    CAS Name: (3a,4b,7a)-12,13-Epoxy-3,4,7,15-tetrahydroxytrichothec-9-en-8-one
    Additional Names: 3a,4b,7a,15-tetrahydroxyscirp-9-en-8-one
    Percent Composition: C 57.68%, H 6.45%, O 35.86%
    Literature References: Trichothecene mycotoxin isolated from Fusarium nivale: T. Tatsuno et al., Chem. Pharm. Bull. 16, 2519 (1968). Structure: eidem, Tetrahedron Lett. 1969, 2823. Toxicology: T. Tatsuno, Cancer Res. 28, 2393 (1968). Implicated as a chemical warfare agent in Southeast Asia with T-2 toxin, q.v.: N. Wade, Science 214, 34 (1981); R. T. Rosen, J. D. Rosen, Biomed. Mass Spectrom. 9, 443 (1982).

  • Tibezonium Iodide CAS Registry Number: 54663-47-7 替贝碘胺


    CAS Name: N,N-Diethyl-N-methyl-2-[[4-[4-(phenylthio)phenyl]-3H-1,5-benzodiazepin-2-yl]thio]ethanaminium iodide
    Additional Names: diethylmethyl[2-[[4-[p-(phenylthio)phenyl]-3H-1,5-benzodiazepin-...
    Literature References: 1,5-Benzodiazepine deriv with bactericidal activity. Prepn: D. Nardi et al., CH 555347 (1974 to Recordati), C.A. 82, 43480 (1975). Synthesis, physical characteristics, antibacterial activity: eidem, Experientia 31, 440 (1975); eidem, Farmaco Ed. Sci. 30, 248 (1975). Structure activity study: C. Greico et al., ibid. 32, 909 (1977). Antimicrobial activity: M. Veronese et al., Chemotherapy 23, 90 (1977). Toxicity study: D. Nardi et al., Experientia 31, 440 (1975).

  • Biapenem CAS Registry Number: 120410-24-4 比阿培南


    CAS Name: 6-[[(4R,5S,6S)-2-Carboxy-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium inner salt
    Additional Names:...
    Literature References: 1-b-methyl-carbapenem antibiotic. Prepn: T. Kumagai et al., EP 289801; eidem, US 4990613 (1988, 1991 both to Lederle). Total synthesis: Y. Nagao et al., J. Org. Chem. 57, 4243 (1992). Renal dehydropeptidase stability: M. Hikida et al., Antimicrob. Agents Chemother. 36, 481 (1992). In-vitro antimicrobial spectrum: H. M. Wexler et al., J. Antimicrob. Chemother. 33, 629 (1994); H. Y. Chen, D. M. Livermore, ibid. 949. Clinical pharmacokinetics: M. Nakashima et al., Int. J. Clin. Pharmacol. Ther. Toxicol. 31, 70 (1993). Clinical evaluation: H. Meguro et al., Jpn. J. Antibiot. 47, 903 (1994).

  • 免费注册, 助力研发,生产, 销售.

    招募中心

    我们的宗旨: 净化, 简洁, 高效Purifying, concise, efficient !我们的口号: 减少中间商赚差价!

    即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.

    试运营阶段,所有广告业务5折优惠

    分类广告投放

    依据化学成分的不同, 针对不同的企业和产品, 我们提供分类产品广告投放.

    客户展示

    示例图片
    优秀企业推荐
    ×

    通知